Marilyn Lewis
- Virology top 0.5%
- Infectious Diseases top 2%
- Epidemiology top 10%
- Molecular Biology
- Immunology top 10%
- Co-authors
- Mike WestbyIan JamesManos PerrosP. Richard HarriganHernán ValdezElna van der RystJulie MoriMichael Mosley
- Topics
- HIV Research and Treatment (21 papers)HIV/AIDS drug development and treatment (17 papers)HIV/AIDS Research and Interventions (6 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Marilyn Lewis
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 62
- Virology 1.0k
- Infectious Diseases 803
- Epidemiology 265
- Molecular Biology 255
- Immunology 243
Countries citing papers authored by Marilyn Lewis
This map shows the geographic impact of Marilyn Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Lewis more than expected).
Fields of papers citing papers by Marilyn Lewis
This network shows the impact of papers produced by Marilyn Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Lewis. The network helps show where Marilyn Lewis may publish in the future.
Co-authorship network of co-authors of Marilyn Lewis
This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Lewis. A scholar is included among the top collaborators of Marilyn Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Lewis. Marilyn Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | First prospective comparison of genotypic versus phenotypic tropism assays in predicting virologic responses to maraviroc in a phase 3 study. | 1 |
| 2 | 10 | |
| 3 | 6 | |
| 4 | 7 | |
| 5 | 15 | |
| 6 | 7 | |
| 7 | 79 | |
| 8 | 17 | |
| 9 | 31 | |
| 10 | 119 | |
| 11 | 62 | |
| 12 | 20 | |
| 13 | 1 | |
| 14 | 95 | |
| 15 | 10 | |
| 16 | Mutations within GP41 are correlated with coreceptor tropism but do not substantially improve coreceptor usage prediction | 0 |
| 17 | 20 | |
| 18 | 98 | |
| 19 | 12 | |
| 20 | 273 |
About Marilyn Lewis
Marilyn Lewis is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (6 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (803 citations) and Hepatology (127 citations). Marilyn Lewis has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Mike Westby, Ian James, Manos Perros, P. Richard Harrigan, Hernán Valdez, Elna van der Ryst, Julie Mori, Michael Mosley, Giuseppe Ciaramella and Jayvant Heera. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.